Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Protein & Cell|October 23, 2025
Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectivesLingxue Niu, Zhenqiang Deng, Yiyu Jin, et al.Nature Communications|November 28, 2024
A sensitive red/far-red photoswitch for controllable gene therapy in mouse models of metabolic diseasesLongliang Qiao, Lingxue Niu, Meiyan Wang, et al.Cell Chemical Biology|May 12, 2026
Programmable living therapeutics for cancer immunotherapyZhenqiang Deng, Lingxue Niu, Zhihao Wang, et al.Cell Reports. Medicine|April 12, 2024
Sonogenetics-controlled synthetic designer cells for cancer therapy in tumor mouse modelsTian Gao, Lingxue Niu, Xin Wu, et al.Cell Reports. Medicine|October 2, 2025
Designer probiotic-based living drugs for uric acid homeostasis control in hyperuricemic mice and ratsXianyun Gao, Yiyu Jin, Mengyao Liu, et al.Molecular Cell|March 13, 2024
A programmable targeted protein-degradation platform for versatile applications in mammalian cells and miceXiaoding Ma, Jianli Yin, Longliang Qiao, et al.Nature Cancer|March 18, 2025
Engineered bacteria for near-infrared light-inducible expression of cancer therapeuticsLongliang Qiao, Lingxue Niu, Zhihao Wang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2026
A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in MammalsLongliang Qiao, Zhihao Wang, Shasha Tang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2025
Optogenetic-Controlled iPSC-Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in MiceLongliang Qiao, Lingxue Niu, Zhihao Wang, et al.Pageof 1